Biotalys NV (BTLS.BR)
EUR 3.08
(0.98%)
EUR 3.08
(0.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| Operating Expenses | 20.89 Million | 22.53 Million | 18.07 Million | 13.27 Million | 9.24 Million |
| Selling, General and Administrative Expenses | 6.89 Million | 6.66 Million | 6.19 Million | 3.18 Million | 2.2 Million |
| Research and Development Expenses | 16.66 Million | 18.81 Million | 13.88 Million | 11.48 Million | 7.85 Million |
| Other Expenses | -2.66 Million | -3 Million | - | - | - |
| Cost and Expenses | 20.89 Million | 22.53 Million | 18.07 Million | 13.27 Million | 9.24 Million |
| Operating Income | -20.89 Million | -22.53 Million | -18.07 Million | -13.27 Million | -9.24 Million |
| Interest Expense | - | 247 Thousand | 246 Thousand | 86 Thousand | 774 Thousand |
| Income Tax Expense | 56 Thousand | -38 Thousand | 16 Thousand | 13 Thousand | 1000.00 |
| Earnings before Tax | -20.45 Million | -22.76 Million | -16.91 Million | -10.73 Million | -7.66 Million |
| Net Income | -20.51 Million | -22.73 Million | -16.92 Million | -10.75 Million | -7.67 Million |
| Earnings Per Share Basic | -0.65 | -0.74 | -1.10 | -0.36 | -0.26 |
| Earnings Per Share Diluted | -0.65 | -0.74 | -1.10 | -0.36 | -0.26 |
| Weighted Average Shares Outstanding | 31.55 Million | 30.89 Million | 15.42 Million | 30.02 Million | 30.02 Million |
| Weighted Average Shares Outstanding (Diluted) | 31.58 Million | 30.89 Million | 15.42 Million | 30.02 Million | 30.02 Million |
| Gross Margin | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - |
| Profit Margin | - | - | - | - | - |
| EBITDA | -19.51 Million | -20.94 Million | -16.49 Million | -12.31 Million | -8.65 Million |
| Earnings Before Tax Margin | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
| Operating Expenses | 3.28 Million | 3.28 Million | 5.01 Million | 5.01 Million | 5.42 Million | 5.42 Million |
| Selling, General and Administrative Expenses | 1.44 Million | 1.44 Million | 1.69 Million | 1.69 Million | 1.75 Million | 1.75 Million |
| Research and Development Expenses | 2.56 Million | 2.56 Million | 4 Million | 4 Million | 4.33 Million | 4.33 Million |
| Other Expenses | -725.5 Thousand | -725.5 Thousand | -675 Thousand | -675 Thousand | -659 Thousand | -659 Thousand |
| Cost and Expenses | 3.28 Million | 3.28 Million | 5.01 Million | 5.01 Million | 5.42 Million | 5.42 Million |
| Operating Income | -3.28 Million | -3.28 Million | -5.01 Million | -5.01 Million | -5.42 Million | -5.42 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 44.5 Thousand | 44.5 Thousand | 8000.00 | 8000.00 | 20 Thousand | 20 Thousand |
| Earnings before Tax | -3.2 Million | -3.2 Million | -4.91 Million | -4.91 Million | -5.31 Million | -5.31 Million |
| Net Income | -3.24 Million | -3.24 Million | -4.92 Million | -4.92 Million | -5.33 Million | -5.33 Million |
| Earnings Per Share Basic | -0.10 | -0.10 | -0.16 | -0.16 | -0.17 | -0.17 |
| Earnings Per Share Diluted | -0.10 | -0.10 | -0.15 | -0.15 | -0.17 | -0.17 |
| Weighted Average Shares Outstanding | 32.15 Million | 32.15 Million | 31.71 Million | 31.71 Million | 31.36 Million | 31.07 Million |
| Weighted Average Shares Outstanding (Diluted) | 32.15 Million | 32.15 Million | 32.1 Million | 32.1 Million | 31.36 Million | 31.07 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -2.93 Million | -2.93 Million | -4.6 Million | -4.6 Million | -5.14 Million | -5.14 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
ENGI
WTM
RSCZF
6292
MRK
300796